Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04969341 · ClinicalTrials.gov registry record
Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable Populations
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 947
- Enrollment target
NCT04969341: Completed study, sponsored by Thomas Jefferson University.
NCT04969341 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 947 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04969341 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 947 participants
- Enrollment target
Study Summary
This study investigates multi-level barriers to lung cancer screening uptake and adherence to lung cancer screening. Identifying cost- and convenience-related barriers to lung cancer screening may help researchers develop targeted strategies to facilitate screening adherence specifically among vulnerable populations.
Primary Outcome
Individual-level insurance status will be analyzed for association with lung cancer screening adherence. Descriptive analyses of neighborhood factors will be conducted to characterize residential computed tomography (CT)s. Multilevel logistic regression models examining the relationship between screening adherence and each neighborhood factor (i.e., one per model for each CT) and will be adjusted for important individual-level covariates, such as patient age, sex, and smoking status. To address
Interventions
- OTHER Survey Administration
- OTHER Electronic Health Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 947 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2023-05-30 |
What the finished NCT04969341 record still lists
NCT04969341 is an observational study that tracks outcomes without assigning an intervention. The registered 947 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.
NCT04969341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04969341 about?
NCT04969341 is a clinical study titled "Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable Populations". This study investigates multi-level barriers to lung cancer screening uptake and adherence to lung cancer screening. Identifying cost- and convenience-related barriers to lung cancer screening may help researchers develop targeted strategies to facilitate screening adherence specifically among vulne...
What is the current status of trial NCT04969341?
This trial is currently completed. The enrollment target is 947 participants. The study started on 2021-05-05. Estimated completion is 2023-05-30.
What interventions are being tested in trial NCT04969341?
The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT04969341?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06087224 · 947 participants · NA
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI